Global Ganja Report

California's ArcView Market Research and its affiliated BDS Analytics have released a "2019 Update" to the 6th edition of their report on The State of Legal Marijuana Markets, which was published back in June. The Update takes stock of events in the second half of the year, and anticipates that worldwide spending on legal cannabis will grow 39.1% to $17 billion in 2019.

A Chinese delegation to Israel to explore cooperation in the cannabis sector points to the East Asian giant's growing footprint in the global industry. But in a continued contradiction, the People's Republic has possibly the harshest drug laws on Earth—and, where unsanctioned use by the commoners is concerned, cannabis is no exception.

2018 saw historic strides toward the liberation of the cannabis plant, from the proverbial four corners of the Earth—North America to the Antipodes. Canadian legalization garnered big headlines, but there were significant breaks with the global prohibition regime in several other countries—including some seemingly unlikely candidates, in regions where the anti-cannabis stigma is deeply entrenched.

While Canada's move to officially legalize cannabis has been hailed as courageous and historic by advocates around the world, some of the planet's most intolerant governments are reacting with dismay—even threatening to have their own citizens arrested if they indulge in legal marijuana on Canadian sovereign territory.

The global cannabis industry is increasingly dependent on factories in China's industrial zones—and fears being impacted by Trump's trade war with Beijing. Chinese pharmaceutical firms meanwhile explore potential applications of cannabis. Yet possession of herbaceous cannabis can land you before a firing squad in China. Human rights groups express alarm about the furious pace of executions in the People's Republic—outstripping the rest of the world combined. And drug offenses—including pot possession—top the country's capital crimes.

The cannabis prohibition regime in South Korea is a harsh one. Authorities have long been intent on maintaining the official fiction of a "drug-free" nation. But the first crack has appeared in this intolerant edifice, with lawmakers and bureaucrats now moving to approve use of certain imported medical marijuana products.

In a fast and furious exchange of retaliatory tariffs, Donald Trump and Xi Jinping appear to have initiated a trade war this week. If Trump isn't careful, he could risk undermining the very domestic economic buoyancy that has helped sustain his popularity among his base. And the cannabis sector is particularly vulnerable, according to industry insiders.

The seizure by federal agents of some 100 homes around Northern California supposedly used in grow operations financed by criminal networks based in China points to ongoing dilemmas in the state's contraband cannabis economy—which persists even in the wake of legalization.